Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT06059118 · RECRUITING
Trial details
- NCT number
- NCT06059118
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-04
- Primary completion
- 2027-01-04
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.